Martin J. Shea

4.2k citations

22 papers · 3.1k indexed · 3 hit papers · h-index 12

Molecular Biology top 5%
Genetics top 5%
Biomedical Engineering top 10%
Cellular and Molecular Neuroscience top 5%
Electronic, Optical and Magnetic Materials top 10%

Co-authors: Galya Vassileva Andrew P. McMahon Brian A. Parr Allan Bradley Maki Wakamiya Richard R. Behringer Pentao Liu Urs Albrecht
Topics: HER2/EGFR in Cancer Research (6 papers)Monoclonal and Polyclonal Antibodies Research (5 papers)Developmental Biology and Gene Regulation (5 papers)
Cited by: Molecular Biology Developmental Neuroscience Developmental Biology
Journals: Nature Genetics Genes & Development ACS Nano
Partner nations: United States Greece United Kingdom

In The Last Decade

Martin J. Shea

21 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mouse Wnt genes exhibit discrete domains of expression in the early embryonic CNS and limb buds

1993 711 citations Brian A. Parr, Martin J. Shea et al. Development profile →
Requirement for Wnt3 in vertebrate axis formation

1999 710 citations Pentao Liu, Maki Wakamiya et al. Nature Genetics profile →
Wnt-3a regulates somite and tailbud formation in the mouse embryo.

1994 664 citations Martin J. Shea, Galya Vassileva et al. Genes & Development profile →

Peers

Countries citing papers authored by Martin J. Shea

Since Specialization

Citations

This map shows the geographic impact of Martin J. Shea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin J. Shea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin J. Shea more than expected).

Fields of papers citing papers by Martin J. Shea

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin J. Shea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin J. Shea. The network helps show where Martin J. Shea may publish in the future.

Co-authorship network of co-authors of Martin J. Shea

This figure shows the co-authorship network connecting the top 25 collaborators of Martin J. Shea. A scholar is included among the top collaborators of Martin J. Shea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin J. Shea. Martin J. Shea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Interactions between ADGRF1 (GPR110) and extracellular matrix proteins govern its effects on tumorigenesis in HER2‐positive breast cancer 2025 ·British Journal of Pharmacology ·(unknown),Raksha R. Bhat,(unknown),(unknown),Suhas Vasaikar,Sarmistha Nanda,(unknown),Martin J. Shea,Wangjia Cao,Jamunarani Veeraraghavan,Hee‐Yong Kim,Tasneem Bawa‐Khalfe,Tahir Hussain,Xinli Liu,Preethi H. Gunaratne,Rachel Schiff,Meghana V. Trivedi	2
2	Therapeutic Targeting of Nemo-like Kinase in Primary and Acquired Endocrine-resistant Breast Cancer 2021 ·Clinical Cancer Research ·Xian Wang,Jamunarani Veeraraghavan,(unknown),(unknown),Lanfang Qin,Jin-Ah Kim,Ying Tan,(unknown),Yiheng Hu,Ling Lin,Sanghoon Lee,Martin J. Shea,Tamika Mitchell,Shunqiang Li,Matthew J. Ellis,Susan G. Hilsenbeck,Rachel Schiff,Xiao-Song Wang	8
3	A novel role of ADGRF1 (GPR110) in promoting cellular quiescence and chemoresistance in human epidermal growth factor receptor 2‐positive breast cancer 2021 ·The FASEB Journal ·(unknown),Raksha R. Bhat,Lanfang Qin,Suhas Vasaikar,(unknown),Tamika Mitchell,Martin J. Shea,Sarmistha Nanda,(unknown),Bing Zhang,Carmine De Angelis,Rachel Schiff,Meghana V. Trivedi	16
4	Abstract 1077: Acquired neratinib resistance is associated with acquisition of HER2 and PIK3CA mutations and can be overcome using potent drug combinations in HER2-positive breast cancer models 2021 ·Cancer Research ·Jamunarani Veeraraghavan,(unknown),Sarmistha Nanda,(unknown),(unknown),Vidyalakshmi Sethunath,Martin J. Shea,Tamika Mitchell,Meenakshi Anurag,Michael A. Mancini,Irmina Diala,Alshad S. Lalani,Fabio Stossi,C. Kent Osborne,Mothaffar F. Rimawi,Rachel Schiff	1
5	Abstract PD3-09: HER2 L755S mutation is acquired upon resistance to lapatinib and neratinib and confers cross-resistance to tucatinib and trastuzumab in HER2-positive breast cancer cell models 2021 ·Cancer Research ·Jamunarani Veeraraghavan,(unknown),Sarmistha Nanda,Vidyalakshmi Sethunath,Martin J. Shea,Tamika Mitchell,Meenakshi Anurag,Michael A. Mancini,Fabio Stossi,C. Kent Osborne,Mothaffar F. Rimawi,Rachel Schiff	3
6	Abstract 1911: HER2 L755S mutation is associated with acquired resistance to lapatinib and neratinib, and confers cross-resistance to tucatinib in HER2-positive breast cancer models 2020 ·Cancer Research ·Jamunarani Veeraraghavan,(unknown),Sarmistha Nanda,Vidyalakshmi Sethunath,Martin J. Shea,Tamika Mitchell,Meenakshi Anurag,Michael A. Mancini,Fabio Stossi,C. Kent Osborne,Mothaffar F. Rimawi,Rachel Schiff	10
7	In vivo longitudinal imaging of RNA interference‐induced endocrine therapy resistance in breast cancer 2019 ·Journal of Biophotonics ·Nrusingh C. Biswal,Xiaoyong Fu,Jaidip Jagtap,Martin J. Shea,Vijetha Kumar,(unknown),(unknown),Rachel Schiff,Amit Joshi	1
8	The oral selective oestrogen receptor degrader (SERD) AZD9496 is comparable to fulvestrant in antagonising ER and circumventing endocrine resistance 2018 ·British Journal of Cancer ·Agostina Nardone,Hazel M. Weir,Oona Delpuech,H. Shelton Brown,Carmine De Angelis,Maria Letizia Cataldo,Xiaoyong Fu,Martin J. Shea,Tamika Mitchell,Jamunarani Veeraraghavan,Chandandeep Nagi,Mark Pilling,Mothaffar F. Rimawi,Meghana V. Trivedi,Susan G. Hilsenbeck,Gary C. Chamness,Rinath Jeselsohn,C. Kent Osborne,Rachel Schiff	43
9	Abstract PD6-2: FoxA1 gene amplification in ER+ breast cancer mediates endocrine resistance by increasing IL-8 2015 ·Cancer Research ·Xiaoyong Fu,Rinath Jeselsohn,(unknown),Dolores López‐Terrada,Chad J. Creighton,Agostina Nardone,Martin J. Shea,Laura M. Heiser,Pavana Anur,Nicholas Wang,(unknown),Paul T. Spellman,Carolina Gutiérrez,Mothaffar F. Rimawi,Susan G. Hilsenbeck,Joe W. Gray,Myles Brown,C. Kent Osborne,Rachel Schiff	1
10	Therapeutic potential of the dual EGFR/HER2 inhibitor AZD8931 in circumventing endocrine resistance 2014 ·Breast Cancer Research and Treatment ·Gladys Morrison,Xiaoyong Fu,Martin J. Shea,Sarmistha Nanda,Mario Giuliano,Tao Wang,Teresa Klinowska,C. Kent Osborne,Mothaffar F. Rimawi,Rachel Schiff	39
11	Sub-100nm gold nanomatryoshkas improve photo-thermal therapy efficacy in large and highly aggressive triple negative breast tumors 2014 ·Journal of Controlled Release ·Ciceron Ayala‐Orozco,(unknown),Sandra Whaley Bishnoi,Alexander S. Urban,(unknown),Tamika Mitchell,Martin J. Shea,Sarmistha Nanda,Rachel Schiff,Naomi J. Halas,Amit Joshi	71
12	An epigenomic approach to therapy for tamoxifen-resistant breast cancer 2014 ·Cell Research ·Qin Feng,Zheng Zhang,Martin J. Shea,Chad J. Creighton,Cristian Coarfa,Susan G. Hilsenbeck,Rainer B. Lanz,Bin He,Lei Wang,Xiaoyong Fu,Agostina Nardone,Yongcheng Song,James E. Bradner,Nicholas Mitsiades,Constantine S. Mitsiades,C. Kent Osborne,Rachel Schiff,Bert W. O’Malley	151
13	Au Nanomatryoshkas as Efficient Near-Infrared Photothermal Transducers for Cancer Treatment: Benchmarking against Nanoshells 2014 ·ACS Nano ·Ciceron Ayala‐Orozco,(unknown),Mark W. Knight,Alexander S. Urban,Oara Neumann,Sandra Whaley Bishnoi,Shaunak Mukherjee,Amanda M. Goodman,(unknown),Tamika Mitchell,Martin J. Shea,(unknown),Sarmistha Nanda,Rachel Schiff,Naomi J. Halas,Amit Joshi	327
14	Insertion of a Telomere Repeat Sequence into a Mammalian Gene Causes Chromosome Instability 2001 ·Molecular and Cellular Biology ·(unknown),Martin J. Shea,R. Geoffrey Sargent,John H. Wilson	77
15	Requirement for Wnt3 in vertebrate axis formationbreakdown → 1999 ·Nature Genetics ·Pentao Liu,Maki Wakamiya,Martin J. Shea,Urs Albrecht,Richard R. Behringer,Allan Bradley	710
16	The spalt-related gene of Drosophila melanogaster is a member of an ancient gene family, defined by the adjacent, region-specific homeotic gene spalt 1996 ·Development Genes and Evolution ·Rosa Barrio,Martin J. Shea,John P. Carulli,Karen Lipkow,Ulrike Gaul,Götz Frommer,Reinhard Schuh,Herbert Jäckle,Fotis C. Kafatos	34
17	Analysis of Regulatory Elements of the Developmentally Controlled Chorions15Promoter in TransgenicDrosophila 1996 ·Developmental Biology ·Brian D. Mariani,Martin J. Shea,Michael J. Conboy,Irina M. Conboy,D L King,(unknown)	11
18	Mouse Wnt genes exhibit discrete domains of expression in the early embryonic CNS and limb budsbreakdown → 1993 ·Development ·Brian A. Parr,Martin J. Shea,Galya Vassileva,Andrew P. McMahon	711
19	Proteins that bind to Drosophila chorion cis-regulatory elements: a new C2H2 zinc finger protein and a C2C2 steroid receptor-like component. 1990 ·Genes & Development ·Martin J. Shea,D L King,Michael J. Conboy,Brian D. Mariani,Fotis C. Kafatos	196
20	62. Shakespeare’s Macbeth, V, ii, 8-12 1973 ·The Explicator ·Martin J. Shea	1

About Martin J. Shea

Martin J. Shea is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology, having authored 22 papers that have together received 3.1k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Developmental Biology and Gene Regulation (5 papers). The work is most often cited by research in Molecular Biology (2.4k citations), Developmental Neuroscience (120 citations) and Developmental Biology (52 citations). Martin J. Shea has collaborated with scholars based in United States, Greece and United Kingdom. Frequent co-authors include Galya Vassileva, Andrew P. McMahon, Brian A. Parr, Allan Bradley, Maki Wakamiya, Richard R. Behringer, Pentao Liu, Urs Albrecht, Jill A. McMahon and Kevin L. Stark. Their work appears in journals such as Nature Genetics, Genes & Development and ACS Nano.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact